Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Superannuation

Super-backed company develops COVID treatment

A biotech company backed by AustralianSuper, HESTA, Hostplus and Statewide Super has developed a new preventative treatment shown to reduce COVID-19 levels by up to 96%.

Upgrade your subscription to access this article

And gain access to:
  • All website content, including archived news
  • Home page news customisation
  • Tech Zone, your technical resource library
And more
Already A Subscriber?

Read more: Ena Respiratory,  HESTA,  Hostplus,  Statewide Super,  Brandon Capital,  Financial Standard,  AustralianSuper,  Christophe Demaison,  Chris Williams,  Medical Research Commercialisation Fund,  MH Carnegie,  Sam Sicilia,  Sonya Sawtell-Rickson